Comparative Effectiveness – The First Act
FDA Eyes Setting Up Two CER Centers To Leverage Agency Data
Even though FDA does not have explicit statutory authority to mandate that new products are superior to legacy medical interventions, the new centers would provide the agency with strategies to potentially incorporate CER into its new life-cycle approach to regulating health care products. [ Inside Health Reform | Mar 11,
No comments yet.